Showing 1 - 7 results of 7 for search 'Arshad Punjani', query time: 0.02s Refine Results
  1. 1
    A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis

    A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatie... by Pankaj Jariwala, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Left ventricular thrombus in patients with COVID-19 – A case series

    Left ventricular thrombus in patients with COVID-19 – A case series by Pankaj Jariwala, Arshad Punjani, Harikishan Boorugu, Mari Ajay Reddy

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in Indian patients with heart failure with preserved ejection fraction – “ARNI-PRESERVED” study

    Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in Indian patients with heart failure with preserved ejection fraction – “ARNI-PRESERVED” study by Pankaj Jariwala, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Kartik Jadhav

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Myocardial abscess secondary to staphylococcal septicemia: Diagnosis with 3D echocardiography

    Myocardial abscess secondary to staphylococcal septicemia: Diagnosis with 3D echocardiography by Pankaj Jariwala, Arshad Punjani, Shaeq Mirza, Boorugu Harikishan, Dilip Babu Madhawar

    Published 2013-01-01
    Get full text
    Article
  5. 5
    Giant right ventricular clot: Smoking is injurious to veins!

    Giant right ventricular clot: Smoking is injurious to veins! by Pankaj Jariwala, Kartik Pandurang Jadhav, Harikishan Boorugu, Arshad Punjani, Krushna Chandra Mishra

    Published 2021-01-01
    Get full text
    Article
  6. 6
    The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction

    The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failur... by Pankaj Jariwala, Kartik Jadhav, Jagdish Madireddi, Anil Kulkarni, Kashyap Vyas, Arshad Punjani, Harikishan Boorougu, Dilip Babu Madhawar

    Published 2020-11-01
    Get full text
    Article
  7. 7
    ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure with Reduced Ejection Fraction (ADD DAPA trial)

    ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure wi... by Pankaj Jariwala, MD, DNB, DNB, MNAMS, FACC, FSCAI, Kartik Jadhav, MD, DM, Arshad Punjani, MD, Harikishan Boorugu, MD, Ajay Reddy Mari, MD

    Published 2021-09-01
    Get full text
    Article

Search Tools: